Company news
TriSalus Life Sciences, Inc. news in 2023
TriSalus Life Sciences, Inc.'s news releases, calls and decks from 2023, newest first.
TriSalus Reports Third Quarter 2023 Financial Results and Provides Business Update
November 13, 2023
TriSalus Life Sciences to Host Third Quarter 2023 Financial Results Conference Call
November 6, 2023
Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications
November 3, 2023
TriSalus Life Sciences Presents Data for SD-101 Delivered by TriSalus Infusion System for Pancreatic Adenocarcinoma at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 2, 2023
TriSalus Life Sciences Announces Late Breaker and Additional Data Presentations on Liver Metastases and Pancreatic Cancer at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
October 24, 2023
TriSalus Life Sciences Appoints Jodi Devlin as President of TriSalus Therapeutics
September 5, 2023
TriSalus Life Sciences Completes Merger with MedTech Acquisition Corporation
August 9, 2023
MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders
August 1, 2023
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting
June 11, 2023
TriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver Metastases
April 19, 2023
TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business
February 20, 2023
Calls in 2023
Decks in 2023
- Technical Presentation (November 2023)
Technical · 24 slides · Nov 1, 2023
- Investor Presentation (September 2023)
Investor deck · 28 slides · Sep 1, 2023
- SPAC Merger (February 2023)
SPAC merger · 47 slides · February 2023